AIL
GILD icon

AGF Investments LLC’s Gilead Sciences GILD Stock Holding History

AGF Investments LLC’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1.66M Buy
26,933
+12,185
+83% +$768K 0.15% 46
2022
Q2 		$912K Buy
14,748
+960
+7% +$59.4K 0.09% 146
2022
Q1 		$820K Buy
13,788
+1,782
+15% +$114K 0.07% 182
2021
Q4 		$872K Buy
12,006
+2,858
+31% +$197K 0.07% 97
2021
Q3 		$639K Sell
9,148
-546
-6% -$38.4K 0.06% 99
2021
Q2 		$668K Sell
9,694
-846
-8% -$56.5K 0.07% 84
2021
Q1 		$681K Sell
10,540
-2,730
-21% -$176K 0.08% 108
2020
Q4 		$773K Sell
13,270
-9,960
-43% -$601K 0.09% 173
2020
Q3 		$1.47M Sell
23,230
-1,911
-8% -$133K 0.16% 64
2020
Q2 		$1.93M Sell
25,141
-4,659
-16% -$357K 0.2% 57
2020
Q1 		$2.23M Sell
29,800
-16,700
-36% -$1.15M 0.29% 34
2019
Q4 		$3.02M Buy
46,500
+3,885
+9% +$253K 0.56% 34
2019
Q3 		$2.7M Sell
42,615
-412
-1% -$26.9K 0.63% 34
2019
Q2 		$2.91M Buy
43,027
+2,471
+6% +$163K 0.61% 43
2019
Q1 		$2.64M Buy
40,556
+7,713
+23% +$513K 0.59% 53
2018
Q4 		$2.05M Buy
32,843
+312
+1% +$21.8K 0.28% 84
2018
Q3 		$2.51M Sell
32,531
-2,306
-7% -$174K 0.32% 82
2018
Q2 		$2.47K Buy
34,837
+19,123
+122% +$1.35M 0.28% 94
2018
Q1 		$1.19M Buy
15,714
+15,651
+24,843% +$1.24M 0.2% 103
2017
Q4 		$5K Hold
63
– – ﹤0.01% 716
2017
Q3 		$5K Sell
63
-15
-19% -$1.15K ﹤0.01% 713
2017
Q2 		$6K Hold
78
– – ﹤0.01% 681
2017
Q1 		$6K Sell
78
-78
-50% -$5.49K ﹤0.01% 699
2016
Q4 		$12K Buy
+156
New +$11.6K ﹤0.01% 464

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AGF Investments LLC's GILD Position: Q3 2022 in Review

AGF Investments LLC increased its Gilead Sciences (GILD) stake by 83% in Q3 2022, buying an estimated $768K and bringing the position to 26,933 shares worth $1.66M. The position accounts for 0.15% of the portfolio, ranked #46.

AGF Investments LLC first reported a position in GILD in Q4 2016 and has held it in 24 quarters since. The position peaked at $3.02M in Q4 2019. 1,603 funds tracked by Wall St. Rank hold GILD as of Q3 2022.

  • AGF Investments LLC held 26,933 shares of Gilead Sciences worth $1.66M as of Q3 2022.
  • AGF Investments LLC bought 12,185 Gilead Sciences shares in Q3 2022, an estimated $768K.
  • Gilead Sciences made up 0.15% of AGF Investments LLC's portfolio in Q3 2022, its #46 holding.
  • AGF Investments LLC first reported a position in Gilead Sciences in Q4 2016 and has held it in 24 quarters since.
  • AGF Investments LLC's Gilead Sciences position peaked at $3.02M in Q4 2019.
  • 1,603 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2022.

Based on AGF Investments LLC's 13F filing for Q3 2022, filed 10 Nov 2022.